Evidence map›Paper›PMID 42124663›Full record

ArticlebioRxiv : the preprint server for biology2026

Characterization of effects of a neurotropic murine coronavirus infection on Alzheimer's disease neuropathology of 5xFAD mice.

Dominic I Javonillo, Susana Furman, Lucas Le, Kellie Fernandez, Jazmyn Mulford, Vidushi Singla, Roshni Jha, Kate Inman Tsourmas, Nellie E Kwang, Kim N Green and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dominic I JavonilloDepartment of Neurobiology & Behavior, University of California, Irvine.ORCID 0000-0002-4243-8372
Susana FurmanDepartment of Neurobiology & Behavior, University of California, Irvine.
Lucas LeDepartment of Neurobiology & Behavior, University of California, Irvine.
Kellie FernandezDepartment of Neurobiology & Behavior, University of California, Irvine.
Jazmyn MulfordDepartment of Neurobiology & Behavior, University of California, Irvine.
Vidushi SinglaDepartment of Neurobiology & Behavior, University of California, Irvine.
Roshni JhaDepartment of Neurobiology & Behavior, University of California, Irvine.
Kate Inman TsourmasDepartment of Neurobiology & Behavior, University of California, Irvine.
Nellie E KwangDepartment of Neurobiology & Behavior, University of California, Irvine.
Kim N GreenDepartment of Neurobiology & Behavior, University of California, Irvine.
Thomas E LaneDepartment of Neurobiology & Behavior, University of California, Irvine.

Funding

UC Irvine MODEL-ADU54AG054349 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI FRANK M LAFERLA · 2017 to 2026
$71.9M
Defining mechanisms of disease and repair in a viral model of multiple sclerosisR35NS116835 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Thomas E Lane · 2020 to 2026
$5.0M
Role of Disease-Associated Microglia in Alzheimer's diseaseR01AG081599 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Kim Green · 2024 to 2026
$2.3M
Neuroimmunology Training Program at the University of California, IrvineT32NS121727 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Kim Green, Thomas E Lane · 2022 to 2026
$854k
Elucidating the role of microglial Beta-hexosaminidase in microglial regulation of perineuronal nets in homeostasis and Alzheimer's diseaseF31NS141599 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI TSOURMAS, KATE INMAN · 2025 to 2025
$47k
NIA NIH HHS R01 AG081599NIA NIH HHS U54 AG054349NINDS NIH HHS F31 NS141599NINDS NIH HHS R35 NS116835NINDS NIH HHS T32 NS121727
6 · The paper itself

Abstract

Background: Recent studies revealed key immunological mechanisms within the central nervous system (CNS) that contribute to Alzheimer's disease pathology. Additionally, analyses of human AD datasets have also associated viral encephalitis exposure (i.e., viral-induced neuroinflammation) with the development of AD and dementia, highlighting the need to better understand how viral encephalitis and neuroimmune mechanisms within the brain may impact AD pathologies such as Aβ plaque deposition. Intracranial infection of susceptible mice with the neurotropic JHM strain of murine coronavirus (JHMV) results in acute encephalomyelitis characterized by viral infection of glia and a robust inflammatory response comprised of monocytes/macrophages and T cells that aid in controlling viral replication. Methods: To determine how coronavirus-induced encephalitis may impact established Aβ plaque deposition, we intracranially inoculated JHMV into aged 5xFAD model of amyloidosis. We utilize immunohistochemical and biochemical analysis to assess the impact on existing Aβ pathology. We also utilize spatial transcriptomic imaging to explore how viral encephalitis affects cellular responses to plaque pathology with single-cell resolution. Results: In aged 5xFAD mice, JHMV-induced encephalitis at 12 days p.i. resulted in minimal changes to overall Aβ protein within the brain. However, viral encephalitis induces CD4 Conclusions: Together, these findings suggest an attenuated myeloid cell response to Aβ plaque burden in 5xFAD mice following acute viral encephalitis. Future experiments aim to further dissect inflammatory mechanisms between infiltrating myeloid cells, T cells, and the progression of Aβ and tau pathology. Data derived from these experiments will further elucidate the viral-induced neuroimmune mechanisms that affect AD pathology and offer an opportunity to determine how these neuropathologic changes, such as subsequent neuronal damage, occur.

Indexed as

Alzheimer’s diseasecoronavirus infectionmyeloid cellsViral encephalitis

Identifiers

PMID42124663
PMCPMC13160041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.